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Epidermolysis bullosa (EB) is a group of skin diseases 
with different clinical manifestations and varied inheritance 
patterns. Blisters may appear spontaneously or following 
minimal trauma to the skin or mucosa. Aim: this paper aims 
to describe the otorhinolaryngological manifestations and 
esophageal complications related to EB, and the experience 
in treating patients with esophageal stenosis secondary 
to this disease. Materials and method: this descriptive 
study enrolled 60 patients with EB seen from June 1999 to 
December 2006 at the Head and Neck Surgery Service of X 
Hospital, a reference center for EB. Results: the patients’ 
mean age was 14.5 years. Twenty-eight (46.6%) were females 
and 32 (53.4%) were males. Eight (13.4%) were diagnosed 
with epidermolysis bullosa simplex, while 51 (85%) had 
epidermolysis bullosa dystrophica; one (1.6%) patient had 
one acquired EB. Lips, mouth, tongue and ears were the most 
frequently involved sites (32 patients - 53.3%). Dysphagia 
was found in 28 patients (46.6%). After esophageal dilatation 
the symptoms subsided. Conclusion: EB is a rare disease 
and patients must be sent for treatment at reference centers. 
Physicians treating patients for EB must be aware of the 
measures required to improve the quality of the treatment 
provided without putting the patients in harm’s way.
Keywords: epidermolysis bullosa, esophagus, manifestations, 
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INTRODUCTION
Epidermolysis bullosa (EB) is a group of skin di-
seases with different clinical manifestations and varied 
inheritance patterns1-4. Blisters may appear spontaneously 
or following minimal trauma to the skin or mucosa4,5. EB 
affects one in every 50,000 livebirths4. Blisters appear se-
condary to the formation of cleavage planes in skin and 
mucosa2,3,5-7. EB can be divided into three large clinical 
groups: EB simplex (dominant autosomal) with blisters 
located in the epidermis that do not leave scars; junctional 
EB (recessive autosomal) in which blisters form in the 
lamina lucida; and EB dystrophica (dominant or recessi-
ve autosomal) characterized by the presence of atrophy, 
milium cysts, ungueal dystrophies, pigmentary alterations 
and mucosal injuries2,4.
Twenty-three phenotypes of EB are known, with 
varied clinical manifestations ranging from mild to lethal 
cases4. Diagnosis is done based on lesion clinical findings 
and pathology tests4. Electronic microscopy is the golden 
standard for diagnosis, but immunohistochemistry (mono-
clonal antibodies specifically) and molecular biology have 
provided sophisticated definitions of normal skin dermo-
epidermal junction structure and function and alterations 
found on each EB group and subgroup4.
Otorhinolaryngological manifestations are frequent 
in EB6-11. Such manifestations are related to the appearance 
of mucosal blisters (mainly in the oropharynx and eso-
phagus), followed by rupture and hypertrophic scarring, 
leading to frenulum shortening, microstomia, esophageal 
stenosis, laryngeal stenosis, and nasal vestibule stenosis. 
Esophageal stenosis is a complication usually found in 
advanced cases, and remains as one of the main challenges 
in treating this condition12. Descriptive studies analyzing 
this infirmity have not yet been published in Brazil.
This paper aims to describe the otorhinolaryngolo-
gical manifestations of epidermolysis bullosa, defining the 
best clinical and/or surgical approaches to consequently 
reduce patient morbidity and mortality.
MATERIALS AND METHOD
This is a descriptive study that enrolled 60 EB pa-
tients followed and treated from June 1999 to December 
2006. The project was approved by the Ethics Committee 
of our institution under permit 136/05.
All patients were referred to the study by the Minas 
Gerais Association of Families, Friends, and Carriers of 
Epidermolysis Bullosa (AMPAPEB).
The 60 patients underwent a thorough otorhi-
nolaryngological examination. Videofluoroscopy and 
contrast-enhanced x-rays of the esophagus, stomach, and 
duodenum were taken.
Esophageal dilatation was required in selected 
cases. Patients referred to the procedure had clinical 
and radiologic evidences of severe esophageal stenosis. 
Esophageal dilatation was performed using olives. All 
procedures were conducted with general anesthesia with 
propofol, succinylcholine, and midazolam. The procedu-
res were carried out under apnea and mask ventilation 
until the patients recovered. After the procedure patients 
were prescribed steroids between 0.5 and 1mg/kg/5 days, 
analgesic drugs (paracetamol or dipyrone) and ranitidine 
(150mg/10ml) or omeprazole (20mg/12/12hs) for 30 days. 
Treatment course was prolonged depending on the presen-
ce of dyspeptic symptoms. Patients experiencing choking 
and dyspeptic symptoms without significant dysphagia 
took proton pump blockers or H2 receptor blockers in 
the previously prescribed dosages.
RESULTS
Twenty-eight (46.6%) of the 60 patients enrolled in 
the study were females, whereas 32 (53.4%) were males. 
Median age was 14.5 years and time of symptom onset 
varied between birth and 22 years of age.
Eight (13.4%) were clinically diagnosed with EB 
simplex, 51 (85%) with recessive EB dystrophica and one 
(1.6%) with acquired EB.
Esophageal manifestations were found in 28 (46.6%) 
patients. All patients underwent esophageal dilatation 
after esophageal stenosis was confirmed through x-ray 
images (Fig. 1).
Figure 1. Esophageal stenosis in the cricoid constriction
Two esophageal complications were observed: one 
patient submitted to dilatation evolved to an esophageal 
blister post-operatively and had to be hospitalized and 
clinically treated until the blister burst and the patient 
was able to swallow. Another patient had an esophageal 
perforation that evolved to pneumomediastinum and 
pneumoperitonium from the carina to the transverse meso-
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colon. This patient complained of intense retrosternal and 
chest pain while performing respiratory movements post-
operatively. Chest x-rays were done to no diagnostic avail. 
A chest CT scan done subsequently showed a perforation. 
After starting treatment with clindamycin and gentamicin, 
the patient was referred to a drainage procedure covering 
the chest, mediastinum, and abdomen (retroperitonium). 
The patient evolved well and was discharged 30 days later. 
Dysphagia status was improved for all patients submitted 
to esophageal dilatation (Fig. 2).
Figure 2. Patient in the previous figure after dilatation with metal 
olives
Lips, mouth, tongue, and ear were the most fre-
quently involved sites (Fig. 3 and 4), with blisters found 
in 32 (53.3%) patients. Blisters were found in the external 
ear canal of two (3.3%) patients; none of them had signs 
of stenosis in the ear canal. Ulcerative lesions and nostril 
blisters were encountered in 11 (18.3%) patients, three 
(27.2%) of which evolved to nostril stenosis. One (1.6%) 
patient had laryngeal-tracheal alterations (anterior com-
missure stenosis) (Table 1).
No complications related to anesthesia were ob-
served, and none of the patients developed skin lesions 
after the procedures.
Figure 3. Microstomia, shortened frenulum, perioral and oral mucosal 
ulcerations
Figure 4. Scar lesion in the ear (milium).
Table 1. Distribution of 60 patients with epidermolysis bullosa in rela-
tion to gender, subtype, and lesion site.
Clinical characteristics Patients
60(100%)
Gender
Female 28 (46.6%)
Male 32 (53.4%)
Subtype
Epidermolysis bullosa simplex 08
Epidermolysis bullosa dystro-
phica
51
Acquired Epidermolysis bullosa 01
Lesion sites
Esophagus 28
Lips 32
External ear canal 02
Nostrils 11
Larynx 01
660
Brazilian Journal of otorhinolaryngology 74 (5) SeptemBer/octoBer 2008
http://www.rborl.org.br  /  e-mail: revista@aborlccf.org.br
DISCUSSION
Epidermolysis bullosa is observed in a heteroge-
neous set of systemic diseases characterized by abnormal 
skin and mucosal frailty3. Research has recently shed light 
on important genetic defects4. Mutations on collagen type 
VII have been seen in cases of recessive and dominant EB 
dystrophica, while EB simplex has been associated with 
mutations on genes for keratin 5 or 143. Investigation has 
shown that some forms of junctional EB are caused by 
mutations in the laminin gene3. These findings have prac-
tical implications in the development of accurate pre-natal 
diagnosis and gene therapy3.
Depending on the type of epidermolysis bullosa, 
patients may develop phlyctenula in their mouths, eso-
phagus, nostrils, ears, and larynx, resulting in significant 
morbidity6-11,13-15. Iron deficiency anemia is common with 
the blood losses subsequent to blister rupture7.
In relation to extracutaneous involvement, the 
upper gastrointestinal tract is the most frequently involved 
site7,10. Phlyctenula and microstomia may occur and lead 
to dysphagia and odynofagia7. Radiologic findings inclu-
de stenosis, blisters, uneven mucosal surface, and hiatal 
hernia. The esophageal mucosa may be extremely fragile 
in patients with EB dystrophica, and perforation has been 
reported after endoscopy10.
Esophageal blisters usually evolve to scar tissue and 
stenosis and may secondarily lead to dysphagia, one of 
the biggest problems in patients with recessive EB dys-
trophica7. Complications such as esophageal perforation, 
pneumomediastinum, pneumoperitonium, and mediasti-
nitis must be diagnosed as early as possible, as they may 
be fatal conditions12.
Teeth are often compromised in EB patients7,14,16. 
Preventive care is needed and frequent visits to a dental 
care provider are required to keep the teeth clean. Early 
fluorine application is indicated for pediatric patients7,14,16. 
All patients included in our study had poor dental status. 
EB patients have a hard time brushing their teeth, as even 
minimal trauma results in lesions.
Laryngeal involvement is rare. It occurs more fre-
quently in junctional EB than on EB dystrophica or EB 
simplex8,9,13,17. Acute laryngeal involvement by blisters 
evolving to hoarseness and stridor requires immediate 
otorhinolaryngological intervention and possibly a tra-
cheostomy2.
EB patients may be offered regular anesthesia, 
however with greater risk for complication17,18. A recent 
review looked at 129 anesthesia administrations in 32 EB 
patients and found no complications in patients using oro-
tracheal intubation (10 cases), face mask, nerve blockage, 
intramuscular or intravenous agents, and local anesthesia. 
Similarly, no intubation-related complications were found 
in another report including 113 cases of oral intubation 
and 18 of nasal intubation done on 33 EB patients17. It 
is possible that the pseudostratified columnar epithelium 
that covers most of the larynx and trachea reduces the 
formation of friction blisters17. Despite their low risk of 
complication, any instrument that contacts skin and muco-
sa (face mask, laryngoscope, and endotracheal tubes) must 
be well lubricated17. Lubricated gauze has been indicated 
to fixate electrodes in cardiac monitoring, pressure cuff 
and venous accesses17.
Complications such as esophageal perforation, 
pneumomediastinum, pneumoperitonium, and mediasti-
nitis must be diagnosed early, as they may be fatal12.
CONCLUSION
EB is a rare disease and patients must be sent to 
reference centers for treatment. Therefore, it is fundamen-
tal that the physicians involved in providing care to these 
patients are aware of the necessary measures to optimize 
the treatment without further harming the patients.
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